Alpine Associates Management Inc. Axonics, Inc. Transaction History
Alpine Associates Management Inc.
- $2.17 Billion
- Q3 2024
A detailed history of Alpine Associates Management Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Alpine Associates Management Inc. holds 2,178,157 shares of AXNX stock, worth $155 Million. This represents 6.99% of its overall portfolio holdings.
Number of Shares
2,178,157
Previous 2,108,871
3.29%
Holding current value
$155 Million
Previous $142 Million
7.03%
% of portfolio
6.99%
Previous 6.8%
Shares
3 transactions
Others Institutions Holding AXNX
# of Institutions
235Shares Held
42.1MCall Options Held
83.4KPut Options Held
65.3K-
Vanguard Group Inc Valley Forge, PA5.06MShares$359 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Fil LTD Hamilton, D02.04MShares$145 Million0.14% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.45MShares$103 Million4.89% of portfolio
-
Omni Event Management LTD London, X01.36MShares$96.6 Million11.9% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...